» Articles » PMID: 32630407

Accuracy of a Semi-Quantitative Ultrasound Method to Determine Liver Fat Infiltration in Early Adulthood

Overview
Specialty Radiology
Date 2020 Jul 8
PMID 32630407
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

An inexpensive and simple method to determine non-alcoholic fatty liver disease (NAFLD) is the abdominal ultrasound, but there are still doubts about its accuracy. We assessed the precision of a semi-quantitative ultrasound method to determine liver fat infiltration, using magnetic resonance spectroscopy (MRS) as the reference. The study was conducted in youths from an ongoing cohort study. Clinical validation was performed, using receiver operating characteristic analysis, in = 60 participants (22.6y; 50% males). Abdominal ultrasound was carried out with liver brightness (score 0-3), diaphragm attenuation (0-2) and liver vessel blurring (0-1) scored by two observers. Liver fat was estimated using MRS. Then, analytical validation was conducted in the remaining participants ( = 555; 22.7y; 51% males) using effects size estimates. An ultrasound score ≥4.0 had the highest sensitivity (78%) and specificity (85%) for NAFLD diagnosis. An area under the curve of 86% denotes a good diagnostic performance of the test, whereas a Kappa of 0.63 suggests substantial agreement of ultrasound vs. MRS. The analytical validation showed that participants having NAFLD according to ultrasound had an unhealthier cardiometabolic profile than participants without the condition. Abdominal ultrasound, combined with a semi-quantitative score system, is a reliable method to determine liver fat infiltration in young adults and should be encouraged whenever MRS is unavailable.

Citing Articles

Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease-Clinical and Pre-Clinical Overview and Systematic Review of the Literature.

Ionita-Radu F, Patoni C, Nancoff A, Marin F, Gaman L, Bucurica A Int J Mol Sci. 2024; 25(8).

PMID: 38673787 PMC: 11050387. DOI: 10.3390/ijms25084201.


Non-Invasive Diagnostic of NAFLD in Type 2 Diabetes Mellitus and Risk Stratification: Strengths and Limitations.

Boeriu A, Dobru D, Fofiu C Life (Basel). 2023; 13(12).

PMID: 38137863 PMC: 10744403. DOI: 10.3390/life13122262.


Profiling of cell-free DNA methylation and histone signatures in pediatric NAFLD: A pilot study.

Buzova D, Braghini M, Bianco S, Lo Re O, Raffaele M, Frohlich J Hepatol Commun. 2022; 6(12):3311-3323.

PMID: 36264206 PMC: 9701487. DOI: 10.1002/hep4.2082.


Multiple events case-control study in a prospective cohort to identify systemic, cellular, and molecular biomarkers of obesity-induced accelerated aging in 30-years-olds: the ObAGE study protocol.

Correa-Burrows P, Burrows R, Albala C, Court F, Salech F, Sanhueza G BMC Geriatr. 2022; 22(1):387.

PMID: 35501766 PMC: 9063300. DOI: 10.1186/s12877-022-03032-4.

References
1.
Ma X, Holalkere N, Kambadakone R A, Mino-Kenudson M, Hahn P, Sahani D . Imaging-based quantification of hepatic fat: methods and clinical applications. Radiographics. 2009; 29(5):1253-77. DOI: 10.1148/rg.295085186. View

2.
Kramer H, Pickhardt P, Kliewer M, Hernando D, Chen G, Zagzebski J . Accuracy of Liver Fat Quantification With Advanced CT, MRI, and Ultrasound Techniques: Prospective Comparison With MR Spectroscopy. AJR Am J Roentgenol. 2016; 208(1):92-100. PMC: 5204456. DOI: 10.2214/AJR.16.16565. View

3.
Kleiner D, Brunt E, Van Natta M, Behling C, Contos M, Cummings O . Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005; 41(6):1313-21. DOI: 10.1002/hep.20701. View

4.
Younossi Z, Anstee Q, Marietti M, Hardy T, Henry L, Eslam M . Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2017; 15(1):11-20. DOI: 10.1038/nrgastro.2017.109. View

5.
Lee D . Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification. Clin Mol Hepatol. 2017; 23(4):290-301. PMC: 5760010. DOI: 10.3350/cmh.2017.0042. View